Abcam, ab238978, Anti-CYP27B1 antibody [EPR20271] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal CYP27B1 antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Human, Rat, Recombinant fragment, Mouse samples. Cited in 1 publication.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR20271,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Mouse, Rat, Human,
Applications:IP, WB, IHC-PSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab238978 is the carrier-free version of
ab206655
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Cytochrome P450 family 27 subfamily B member 1 (CYP27B1) also known as 25-hydroxyvitamin D3 1-alpha-hydroxylase plays a mechanical role in the hydroxylation of 25-hydroxyvitamin D3 into the active form 125-dihydroxyvitamin D3 (calcitriol). This enzyme is approximately 56 kDa in size. Expression is notably high in the kidneys which is the primary site for its enzymatic activity but it is also present in several other tissues including skin lungs and immune cells.
Biological function summary
The active form of vitamin D produced by CYP27B1 is essential for maintaining mineral homeostasis and bone health. The enzyme is not traditionally part of a larger protein complex but works closely with vitamin D binding proteins to interact with its substrates. The active vitamin D influences calcium and phosphate balance in the body which has implications for overall bone integrity and immune system regulation.
Pathways
CYP27B1 plays a significant role in the vitamin D metabolic pathway and the calcium signaling pathway. It functions upstream of the vitamin D receptor (VDR) that helps control calcium absorption in the gut. CYP24A1 another related cytochrome P450 enzyme participates in degrading the active form of vitamin D maintaining an important balance within the system. Together these pathways and proteins help regulate calcium levels critical to many physiological processes.
CYP27B1 has notable connections to rickets and osteoporosis. Mutations in the CYP27B1 gene can lead to reduced or absent enzyme activity resulting in Vitamin D-dependent rickets type 1 characterized by impaired bone mineralization. Its activity also affects osteoporosis a condition of reduced bone density. The balance between CYP27B1 and CYP24A1 is important in understanding the pathogenesis of these bone-related disorders where altered vitamin D metabolism can contribute to disease development.